Journal article

Sun exposure and vitamin D are independent risk factors for CNS demyelination

RM Lucas, A-L Ponsonby, K Dear, PC Valery, MP Pender, BV Taylor, TJ Kilpatrick, T Dwyer, A Coulthard, C Chapman, I van der Mei, D Williams, AJ McMichael

Neurology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2011

Grants

Funding Acknowledgements

Supported by the National Multiple Sclerosis Society of the United States of America, the National Health and Medical Research Council of Australia, the ANZ William Buckland Foundation, and Multiple Sclerosis Research Australia.Dr. Lucas receives research support from Multiple Sclerosis Research Australia, The Royal Australasian College of Physicians, and the National Health and Medical Research Council of Australia. Dr. Ponsonby receives research support from Multiple Sclerosis Research Australia and the National Health and Medical Research Council of Australia. Dr. Dear receives research support from Multiple Sclerosis Research Australia and the National Health and Medical Research Council of Australia. Dr. Valery receives research support from the National Health and Medical Research Council of Australia and the Australian Research Council. Dr. Pender serves on the editorial board of The Open Autoimmunity Journal; and receives research support from Multiple Sclerosis Research Australia and from the National Health and Medical Research Council of Australia. Dr. Taylor has received funding for travel and speaker honoraria from Bayer Schering Pharma and CSL Australia Pty Ltd.; served on the editorial advisory board of the International MS Journal; and receives/has received research support from the National Health and Medical Research Council of Australia, The Health Research Council of New Zealand, the National MS Society of USA, and the MS Society of Tasmania. Dr. Kilpatrick has served on scientific advisory boards for GlaxoSmithKline, Neurosciences Victoria, and the Victorian Neurotrauma Initiative; has received funding for travel from Bayer Schering Pharma and Merck Serono; served on the editorial board of Therapeutic Advances in Neurological Disorders; is listed as an inventor on patents re: HIV test kit method for detecting anti-HIV-I antibodies in saliva; A method of modulating cell survival and reagents useful for same; Methods for the treatment and prophylaxis of demyelinating disease; and Method of treatment in the field of inflammatory neurodegeneration; and receives research support from Bayer Schering Pharma, Biogen Idec, the Australian Research Council, the National Health and Medical Research Council of Australia, MS Research Australia, and the National Multiple Sclerosis Society. Dr. Dwyer receives research support from the National Health and Medical Research Council of Australia. Dr. Coulthard serves as an associate Editor of the Journal of Medical Imaging and Radiation Oncology. Dr. Chapman reports no disclosures. Dr. van der Mei receives research support from MS Research Australia and the National Health and Medical Research Council of Australia. Dr. Williams reports no disclosures. Dr. McMichael serves on editorial advisory boards for Environment Health Perspectives, Cancer Causes and Control, and EcoHealth; and receives research support from the National Health and Medical Research Council and the Poola Foundation.